Literature DB >> 1561182

Angiotensin converting enzyme inhibitors for hypertension and heart failure?

J G Cleland1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1561182      PMCID: PMC2399306          DOI: 10.1136/pgmj.68.795.1

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  21 in total

1.  Efficacy of captopril before thrombolysis in acute myocardial infarction: preliminary findings.

Authors:  P Di Pasquale; G Barone; S Paterna; S Cannizzaro; A Giubilato
Journal:  Drugs Exp Clin Res       Date:  1990

2.  The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization, and outcome definitions.

Authors:  A S Hall; C Winter; S M Bogle; A F Mackintosh; G D Murray; S G Ball
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

3.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study.

Authors:  H Pouleur; M F Rousseau; C Oakley; L Rydén
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

5.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

Authors:  P H Held; S Yusuf; C D Furberg
Journal:  BMJ       Date:  1989-11-11

6.  Metaraminol-induced reversal of acute myocardial ischaemia associated with hypotension and refractory to intravenous nitroglycerin.

Authors:  J Figueras; R M Lidon; J Cortadellas
Journal:  Eur Heart J       Date:  1991-06       Impact factor: 29.983

7.  Neuroendocrine activation after acute myocardial infarction.

Authors:  H M McAlpine; J J Morton; B Leckie; A Rumley; G Gillen; H J Dargie
Journal:  Br Heart J       Date:  1988-08

8.  A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.

Authors:  R DiBianco; R Shabetai; W Kostuk; J Moran; R C Schlant; R Wright
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

9.  Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

Authors:  P R Lichtlen; P G Hugenholtz; W Rafflenbeul; H Hecker; S Jost; J W Deckers
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

10.  Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure.

Authors:  D M Mancini; H Eisen; W Kussmaul; R Mull; L H Edmunds; J R Wilson
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  2 in total

1.  Angiotensin converting enzyme inhibitors for hypertension and heart failure?

Authors:  T O Cheng
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

2.  Oesophageal tuberculosis mimicking a tumour during treatment for nodal tuberculosis.

Authors:  U Kaur; S Katariya; S R Bhusnurmath; P Bambery; J B Dilawari
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.